Below is a list of Healthcare & Life Sciences materials related to COVID-19.
Please click the images below our articles if you would like to filter content by another department.
Regulatory Flexibility - Key Measures to Support Availability of Medicines and Medical Devices During COVID-19
The COVID-19 pandemic has propelled the healthcare and life sciences industries into uncharted territory. We explore the flexibility of regulators at a national and European level enabling accelerated approval of pharmaceuticals and medical devices so that demand emanating from this global health crisis can be met. Read more here...
Competition Law and COVID-19
Competition law continues to apply during the COVID-19 pandemic. Enforcement is likely to target key healthcare/medical products. Read more here...
Compulsory Licences on the Horizon for Drugs and Equipment?
As concerns grow globally about the availability of certain drugs and equipment in the midst of the COVID-19 pandemic will we see other governments follow Israel and start to issue compulsory licences? Read more here...
Emergency Measures to Halt the Spread of COVID-19
Government passes emergency COVID-19 Legislation. Read more
here...